Mechanisms of impaired β-adrenergic receptor signaling in G(αq)- mediated cardiac hypertrophy and ventricular dysfunction

Gerald W. Dorn, Nicole M. Tepe, Guangyu Wu, Atsuko Yatani, Stephen B. Liggett

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Targeted cardiac overexpression of the α-subunit of the heterotrimeric G protein G(q) in transgenic mice evokes hypertrophy and depressed stimulation of cardiac inotropy and chronotropy by β-adrenergic receptor (βAR) agonists in vivo, which is a hallmark of many forms of experimental and human heart failure. The molecular basis of this βAR dysfunction was explored in transgenic mice overexpressing G(αq) ~5-fold over background. Isoproterenol-stimulated adenylyl cyclase activities in myocardial membranes were significantly depressed in G(αq) mice compared with nontransgenic controls (19.7 ± 2.6 versus 43.7 ± 5.6 pmol/min/mg) without a decrease in βAR expression levels. Functional coupling of both βAR subtypes was impaired. Similarly, in whole-cell patch-clamp studies, βAR stimulation of L-type Ca 2+ channel currents was depressed ~75% in the G(αq) mice. Cardiac βAR from these mice showed decreased formation of the active high- affinity conformation (R(H) = 29% versus 62% for nontransgenic littermates), confirming a receptor-G(s)-coupling defect. Of the three candidate kinases that might impose this uncoupling by receptor phosphorylation (protein kinase A, βAR kinase, protein kinase C), only protein kinase C activity was elevated in G(αq) mouse hearts. Type V adenylyl cyclase was decreased ~45% in these mice, consistent with decreased basal, NaF, and forskolin-stimulated enzyme activities. Although cellular G(s) levels were unaltered, G(i2) and G(i3) were increased in G(αq) mice. Pertussis toxin treatment of isolated G(αq) myocytes resulted in an improvement in βAR, but not that of forskolin or NaF, stimulation of adenylyl cyclase. This three distinct mechanisms contribute to impaired βAR function by in vivo G(q) signaling cross-talk in myocytes. Because many elements of hypertrophy and/or failure in cellular and animal models can be initiated by increased G(αq) signaling, the current work may be broadly applicable to interfaces whereby modification of heart failure might be considered.

Original languageEnglish (US)
Pages (from-to)278-287
Number of pages10
JournalMolecular Pharmacology
Volume57
Issue number2
StatePublished - Feb 17 2000
Externally publishedYes

Fingerprint

Ventricular Dysfunction
Cardiomegaly
Adrenergic Receptors
Colforsin
Adenylyl Cyclases
Muscle Cells
Hypertrophy
Transgenic Mice
Heart Failure
Heterotrimeric GTP-Binding Proteins
Adrenergic Agonists
Pertussis Toxin
Cyclic AMP-Dependent Protein Kinases
Isoproterenol
Protein Kinase C
Phosphotransferases
Animal Models
Heart Rate
Phosphorylation
Membranes

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Mechanisms of impaired β-adrenergic receptor signaling in G(αq)- mediated cardiac hypertrophy and ventricular dysfunction. / Dorn, Gerald W.; Tepe, Nicole M.; Wu, Guangyu; Yatani, Atsuko; Liggett, Stephen B.

In: Molecular Pharmacology, Vol. 57, No. 2, 17.02.2000, p. 278-287.

Research output: Contribution to journalArticle

Dorn, Gerald W. ; Tepe, Nicole M. ; Wu, Guangyu ; Yatani, Atsuko ; Liggett, Stephen B. / Mechanisms of impaired β-adrenergic receptor signaling in G(αq)- mediated cardiac hypertrophy and ventricular dysfunction. In: Molecular Pharmacology. 2000 ; Vol. 57, No. 2. pp. 278-287.
@article{8177ca75e06347c3bfb3a39a07e122df,
title = "Mechanisms of impaired β-adrenergic receptor signaling in G(αq)- mediated cardiac hypertrophy and ventricular dysfunction",
abstract = "Targeted cardiac overexpression of the α-subunit of the heterotrimeric G protein G(q) in transgenic mice evokes hypertrophy and depressed stimulation of cardiac inotropy and chronotropy by β-adrenergic receptor (βAR) agonists in vivo, which is a hallmark of many forms of experimental and human heart failure. The molecular basis of this βAR dysfunction was explored in transgenic mice overexpressing G(αq) ~5-fold over background. Isoproterenol-stimulated adenylyl cyclase activities in myocardial membranes were significantly depressed in G(αq) mice compared with nontransgenic controls (19.7 ± 2.6 versus 43.7 ± 5.6 pmol/min/mg) without a decrease in βAR expression levels. Functional coupling of both βAR subtypes was impaired. Similarly, in whole-cell patch-clamp studies, βAR stimulation of L-type Ca 2+ channel currents was depressed ~75{\%} in the G(αq) mice. Cardiac βAR from these mice showed decreased formation of the active high- affinity conformation (R(H) = 29{\%} versus 62{\%} for nontransgenic littermates), confirming a receptor-G(s)-coupling defect. Of the three candidate kinases that might impose this uncoupling by receptor phosphorylation (protein kinase A, βAR kinase, protein kinase C), only protein kinase C activity was elevated in G(αq) mouse hearts. Type V adenylyl cyclase was decreased ~45{\%} in these mice, consistent with decreased basal, NaF, and forskolin-stimulated enzyme activities. Although cellular G(s) levels were unaltered, G(i2) and G(i3) were increased in G(αq) mice. Pertussis toxin treatment of isolated G(αq) myocytes resulted in an improvement in βAR, but not that of forskolin or NaF, stimulation of adenylyl cyclase. This three distinct mechanisms contribute to impaired βAR function by in vivo G(q) signaling cross-talk in myocytes. Because many elements of hypertrophy and/or failure in cellular and animal models can be initiated by increased G(αq) signaling, the current work may be broadly applicable to interfaces whereby modification of heart failure might be considered.",
author = "Dorn, {Gerald W.} and Tepe, {Nicole M.} and Guangyu Wu and Atsuko Yatani and Liggett, {Stephen B.}",
year = "2000",
month = "2",
day = "17",
language = "English (US)",
volume = "57",
pages = "278--287",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Mechanisms of impaired β-adrenergic receptor signaling in G(αq)- mediated cardiac hypertrophy and ventricular dysfunction

AU - Dorn, Gerald W.

AU - Tepe, Nicole M.

AU - Wu, Guangyu

AU - Yatani, Atsuko

AU - Liggett, Stephen B.

PY - 2000/2/17

Y1 - 2000/2/17

N2 - Targeted cardiac overexpression of the α-subunit of the heterotrimeric G protein G(q) in transgenic mice evokes hypertrophy and depressed stimulation of cardiac inotropy and chronotropy by β-adrenergic receptor (βAR) agonists in vivo, which is a hallmark of many forms of experimental and human heart failure. The molecular basis of this βAR dysfunction was explored in transgenic mice overexpressing G(αq) ~5-fold over background. Isoproterenol-stimulated adenylyl cyclase activities in myocardial membranes were significantly depressed in G(αq) mice compared with nontransgenic controls (19.7 ± 2.6 versus 43.7 ± 5.6 pmol/min/mg) without a decrease in βAR expression levels. Functional coupling of both βAR subtypes was impaired. Similarly, in whole-cell patch-clamp studies, βAR stimulation of L-type Ca 2+ channel currents was depressed ~75% in the G(αq) mice. Cardiac βAR from these mice showed decreased formation of the active high- affinity conformation (R(H) = 29% versus 62% for nontransgenic littermates), confirming a receptor-G(s)-coupling defect. Of the three candidate kinases that might impose this uncoupling by receptor phosphorylation (protein kinase A, βAR kinase, protein kinase C), only protein kinase C activity was elevated in G(αq) mouse hearts. Type V adenylyl cyclase was decreased ~45% in these mice, consistent with decreased basal, NaF, and forskolin-stimulated enzyme activities. Although cellular G(s) levels were unaltered, G(i2) and G(i3) were increased in G(αq) mice. Pertussis toxin treatment of isolated G(αq) myocytes resulted in an improvement in βAR, but not that of forskolin or NaF, stimulation of adenylyl cyclase. This three distinct mechanisms contribute to impaired βAR function by in vivo G(q) signaling cross-talk in myocytes. Because many elements of hypertrophy and/or failure in cellular and animal models can be initiated by increased G(αq) signaling, the current work may be broadly applicable to interfaces whereby modification of heart failure might be considered.

AB - Targeted cardiac overexpression of the α-subunit of the heterotrimeric G protein G(q) in transgenic mice evokes hypertrophy and depressed stimulation of cardiac inotropy and chronotropy by β-adrenergic receptor (βAR) agonists in vivo, which is a hallmark of many forms of experimental and human heart failure. The molecular basis of this βAR dysfunction was explored in transgenic mice overexpressing G(αq) ~5-fold over background. Isoproterenol-stimulated adenylyl cyclase activities in myocardial membranes were significantly depressed in G(αq) mice compared with nontransgenic controls (19.7 ± 2.6 versus 43.7 ± 5.6 pmol/min/mg) without a decrease in βAR expression levels. Functional coupling of both βAR subtypes was impaired. Similarly, in whole-cell patch-clamp studies, βAR stimulation of L-type Ca 2+ channel currents was depressed ~75% in the G(αq) mice. Cardiac βAR from these mice showed decreased formation of the active high- affinity conformation (R(H) = 29% versus 62% for nontransgenic littermates), confirming a receptor-G(s)-coupling defect. Of the three candidate kinases that might impose this uncoupling by receptor phosphorylation (protein kinase A, βAR kinase, protein kinase C), only protein kinase C activity was elevated in G(αq) mouse hearts. Type V adenylyl cyclase was decreased ~45% in these mice, consistent with decreased basal, NaF, and forskolin-stimulated enzyme activities. Although cellular G(s) levels were unaltered, G(i2) and G(i3) were increased in G(αq) mice. Pertussis toxin treatment of isolated G(αq) myocytes resulted in an improvement in βAR, but not that of forskolin or NaF, stimulation of adenylyl cyclase. This three distinct mechanisms contribute to impaired βAR function by in vivo G(q) signaling cross-talk in myocytes. Because many elements of hypertrophy and/or failure in cellular and animal models can be initiated by increased G(αq) signaling, the current work may be broadly applicable to interfaces whereby modification of heart failure might be considered.

UR - http://www.scopus.com/inward/record.url?scp=0033950466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033950466&partnerID=8YFLogxK

M3 - Article

VL - 57

SP - 278

EP - 287

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 2

ER -